Apollo Endosurgery, Inc. (APEN)
Chart Events
Performance Outlook
| Previous Close | 7.98 |
| Open | 8.00 |
| Bid | 7.78 x 1200 |
| Ask | 8.35 x 800 |
| Day's Range | 7.79 - 8.00 |
| 52 Week Range | 1.25 - 9.01 |
| Volume | 22,320 |
| Avg. Volume | 124,342 |
| Market Cap | 210.879M |
| Beta (5Y Monthly) | 2.35 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.99 |
| Earnings Date | Feb 25, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.33 |
- ACCESSWIRE
Apollo Endosurgery Appoints Jeffrey G. Black as Chief Financial Officer
Veteran Executive Brings 30 Years of Financial and Operational Leadership ExperienceAUSTIN, TX / ACCESSWIRE / July 16, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced the hiring of Jeffrey G.
- Simply Wall St.
Here's What Apollo Endosurgery, Inc.'s (NASDAQ:APEN) Shareholder Ownership Structure Looks Like
If you want to know who really controls Apollo Endosurgery, Inc. ( NASDAQ:APEN ), then you'll have to look at the...
- ACCESSWIRE
MERIT Study Investigators Announce Successful Achievement of the Study's Primary Efficacy & Safety Endpoints
AUSTIN, TX / ACCESSWIRE / June 14, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced that investigators of the Multi-Center ESG Randomized Interventional (MERIT) study have reported based on a preliminary analysis the successful achievement of the study's primary endpoints.
